PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+2.69%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$734M
AUM Growth
+$734M
(-9.9%)
Cap. Flow
-$47.7M
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
35.85%
Holding
111
New
11
Increased
44
Reduced
34
Closed
21
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$19.2M |
| 2 |
Insulet
PODD
|
$17.8M |
| 3 |
Icon
ICLR
|
$11.6M |
| 4 |
Humana
HUM
|
$11.2M |
| 5 |
Boston Scientific
BSX
|
$9.71M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$17.9M |
| 2 |
Inspire Medical Systems
INSP
|
$17.4M |
| 3 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$15.6M |
| 4 |
Cencora
COR
|
$13.5M |
| 5 |
Oscar Health
OSCR
|
$12.4M |
Sector Composition
| 1 | Healthcare | 99.93% |
| 2 | Industrials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Boston Scientific
BSX
$156B
| $42.5M | 5.69% | 551,592 +126,119 | +30% | +$9.71M |
|
|
2
Insulet
PODD
$23.9B
| $36.2M | 4.85% | 179,305 +88,356 | +97% | +$17.8M |
|
3
United Therapeutics
UTHR
$13.8B
| $35.5M | 4.75% | 111,381 -16,818 | -13% | -$5.36M |
|
4
Eli Lilly
LLY
$657B
| $28.7M | 3.84% | 31,654 -463 | -1% | -$419K |
|
5
Cooper Companies
COO
$13.4B
| $26.9M | 3.61% | 308,398 +22,999 | +8% | +$2.01M |
|
|
6
Tenet Healthcare
THC
$16.3B
| $19.8M | 2.65% | 148,927 -134,926 | -48% | -$17.9M |
|
|
7
Agios Pharmaceuticals
AGIO
$2.19B
| $19.2M | 2.58% | +446,416 | New | +$19.2M |
|
|
LBPH
8
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $18.8M | 2.51% | 694,178 +1,034 | +0.1% | +$27.9K |
|
9
RxSight
RXST
$370M
| $17.9M | 2.39% | 296,739 -115,693 | -28% | -$6.96M |
|
10
DexCom
DXCM
$29.5B
| $17.8M | 2.38% | 156,855 -14,810 | -9% | -$1.68M |
|
11
Becton Dickinson
BDX
$55.3B
| $15.9M | 2.13% | 68,167 +22,570 | +49% | +$5.27M |
|
12
Neurocrine Biosciences
NBIX
$13.8B
| $15.9M | 2.12% | 115,170 -16,781 | -13% | -$2.31M |
|
13
Elevance Health
ELV
$71.8B
| $15M | 2.01% | 27,751 +12,587 | +83% | +$6.82M |
|
14
Schrodinger
SDGR
$1.44B
| $14M | 1.87% | 721,373 -278,641 | -28% | -$5.39M |
|
|
ITCI
15
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12.7M | 1.7% | 185,028 +115,136 | +165% | +$7.89M |
|
16
Abbott
ABT
$231B
| $12.7M | 1.7% | 121,913 +224 | +0.2% | +$23.3K |
|
17
MannKind Corp
MNKD
$1.41B
| $12.6M | 1.68% | 2,409,599 +3,663 | +0.2% | +$19.1K |
|
18
Day One Biopharmaceuticals
DAWN
$769M
| $12.5M | 1.68% | 908,822 +217,010 | +31% | +$2.99M |
|
19
Syndax Pharmaceuticals
SNDX
$1.41B
| $12.3M | 1.65% | 600,698 -184,113 | -23% | -$3.78M |
|
20
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $12.1M | 1.62% | 647,142 +979 | +0.2% | +$18.3K |
|
|
21
Icon
ICLR
$13.8B
| $11.6M | 1.56% | +37,056 | New | +$11.6M |
|
22
Vaxcyte
PCVX
$4B
| $11.3M | 1.52% | 150,191 +235 | +0.2% | +$17.7K |
|
|
23
Humana
HUM
$36.5B
| $11.2M | 1.5% | +30,037 | New | +$11.2M |
|
|
BCYC
24
Bicycle Therapeutics
BCYC
$511M
| $10.8M | 1.45% | 535,063 +10,810 | +2% | +$219K |
|
25
Edgewise Therapeutics
EWTX
$1.51B
| $10.3M | 1.39% | 574,517 -79,136 | -12% | -$1.43M |
|